Literature DB >> 9570915

A simple immunomagnetic protocol for the selective isolation and long-term culture of human dermal microvascular endothelial cells.

L Richard1, P Velasco, M Detmar.   

Abstract

Endothelial cells involved in tumor angiogenesis, wound healing, and inflammation are predominantly of microvascular origin and are functionally distinct from large vessel-derived endothelial cells which have been largely used for in vitro vascular research. To overcome the problems commonly involved in the culture of microvascular endothelial cells, including unreliable isolation techniques and low cell yields, we developed a simplified protocol for the selective cultivation of human dermal microvascular endothelial cells (HDMEC) obtained from neonatal foreskins, based on the transient, endothelial cell-specific induction of E-selection by tumor necrosis factor-alpha (TNF-alpha). Subconfluent primary cultures, consisting of a mixture of endothelial cells, fibroblasts, and keratinocytes, were treated with TNF-alpha for 6 h, and HDMEC were isolated by their selective binding to magnetic beads coupled with anti-E-selection monoclonal antibody. After two immunomagnetic purification steps, a homogenous population of HDMEC was obtained which showed typical cobblestone morphology, expressed CD31 and von Willebrand factor, proliferated in response to vascular endothelial growth factor, upregulated the expression of intercellular adhesion molecule-1 and vascular adhesion molecule-1 in response to TNF-alpha, and formed capillary-like tubes in a three-dimensional collagen type I matrix. This simple technique may facilitate a more widespread use of microvascular endothelial cell cultures obtained from different human or animal organs for functional in vitro studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9570915     DOI: 10.1006/excr.1998.3936

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  45 in total

1.  The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest.

Authors:  J R Yeh; R Mohan; C M Crews
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  The biocompatibility of titanium cardiovascular devices seeded with autologous blood-derived endothelial progenitor cells: EPC-seeded antithrombotic Ti implants.

Authors:  Hardean E Achneck; Ryan M Jamiolkowski; Alexandra E Jantzen; Justin M Haseltine; Whitney O Lane; Jessica K Huang; Lauren J Galinat; Michael J Serpe; Fu-Hsiung Lin; Madison Li; Amar Parikh; Liqiao Ma; Tao Chen; Bantayehu Sileshi; Carmelo A Milano; Charles S Wallace; Thomas V Stabler; Jason D Allen; George A Truskey; Jeffrey H Lawson
Journal:  Biomaterials       Date:  2010-11-05       Impact factor: 12.479

3.  Dermatan sulfate activates nuclear factor-kappab and induces endothelial and circulating intercellular adhesion molecule-1.

Authors:  S F Penc; B Pomahac; E Eriksson; M Detmar; R L Gallo
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

4.  Rho activity critically and selectively regulates endothelial cell organization during angiogenesis.

Authors:  Mien V Hoang; Mary C Whelan; Donald R Senger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

5.  Molecular characterization of lymphatic endothelial cells.

Authors:  Simona Podgrabinska; Pascal Braun; Paula Velasco; Bryan Kloos; Michael S Pepper; Mihaela Skobe
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-22       Impact factor: 11.205

6.  RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development.

Authors:  Irit Adini; Isaac Rabinovitz; Jing Fang Sun; George C Prendergast; Laura E Benjamin
Journal:  Genes Dev       Date:  2003-11-01       Impact factor: 11.361

7.  Angiopoietin-1 and vascular endothelial growth factor regulation of leukocyte adhesion to endothelial cells: role of nuclear receptor-77.

Authors:  Hodan Ismail; Mahroo Mofarrahi; Raquel Echavarria; Sharon Harel; Eric Verdin; Hyung W Lim; Zheng-Gen Jin; Jianxin Sun; Huiyan Zeng; Sabah N A Hussain
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-24       Impact factor: 8.311

Review 8.  Cell-based approaches to the engineering of vascularized bone tissue.

Authors:  Rameshwar R Rao; Jan P Stegemann
Journal:  Cytotherapy       Date:  2013-08-31       Impact factor: 5.414

9.  Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells.

Authors:  Wiltrud Lederle; Hans-Jürgen Stark; Mihaela Skobe; Norbert E Fusenig; Margareta M Mueller
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

10.  The C-terminal domain of A1/Bfl-1 regulates its anti-inflammatory function in human endothelial cells.

Authors:  Renata P Guedes; Eduardo Rocha; Jerome Mahiou; Herwig P Moll; Maria B Arvelo; Janis M Taube; Clayton R Peterson; Elzbieta Kaczmarek; Christopher R Longo; Cleide G da Silva; Christiane Ferran
Journal:  Biochim Biophys Acta       Date:  2013-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.